Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Identifying budgeting challenges helps you target improvements. This guide outlines practical methods to pinpoint where your budget struggles.
11,304 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A SpaceX AI push could rewrite how we think about tech bets. If spacex just spent billion, investors should watch how...
Creativity is the secret fuel for a joyful, purposeful retirement. This guide shows practical ways to use creative en...
A new look at professional political leanings shows growing support for socialist ideas among white-collar workers, w...
NVIDIA, under Jensen Huang, has built more than chips—it's crafted an AI compute ecosystem. This article explains why...
Memory stocks look risky on the surface, yet the fundamentals are unusually strong. This article decodes what history...
Imagine turning a modest $100 monthly investment into a meaningful future. This guide breaks down how a stock that co...
A major fund recently sold its entire NIO position for about $79.8 million. This article breaks down what happened, w...
A practical, investor-focused look at delcath (dcth) 2025 earnings prospects. We break down the catalysts, risks, and...
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
Aehr Test Systems stock jumped 46% in a single month amid upbeat contract news and rising demand for burn-in testing....
A leading infrastructure stock surged 124% in the past year, even as a major fund dumped roughly $38 million of its s...